Vector-borne diseases (VBDs) constitute a significant public health challenge in India, contributing to morbidity and mortality rates. This article aims to provide healthcare professionals with a comprehensive review of the prevalence and impact of VBDs in India.
VBDs, including malaria, dengue, and chikungunya, are endemic in India. The World Health Organization (WHO) reports that India accounts for 4% of global malaria cases. Dengue, with its rapid urban spread, has seen a drastic increase, with over 100,000 cases reported annually. Chikungunya, although less prevalent, has caused significant outbreaks in recent years.
The impact of VBDs on India's public health system is profound. Beyond the immediate health implications, these diseases have socio-economic consequences, burdening the healthcare system and affecting productivity due to illness-related work absences. Additionally, the cost of managing and controlling these diseases is substantial, straining limited resources.
India's diverse geography and climate, coupled with high population density, create a conducive environment for vectors. This, coupled with inadequate public health infrastructure, exacerbates the VBD challenge. However, opportunities for improvement exist. Enhancing disease surveillance, improving diagnostic capabilities, and strengthening vector control programs can significantly mitigate the impact of VBDs.
Understanding the prevalence and impact of VBDs is crucial for healthcare professionals in India. This knowledge can guide disease control strategies, inform policy-making, and enable better patient care. As we continue to grapple with these diseases, a comprehensive, multi-sectoral approach that includes improved surveillance, diagnostics, vector control, and community engagement is imperative to reduce the burden of VBDs in India.
1.
AI-based liquid biopsy shows promise for detecting brain cancer
2.
To refute accusations that it failed to issue a cancer warning, Roundup's maker is asking lawmakers for assistance.
3.
Aspirin Fails to Boost Survival in Colorectal Cancer Trial
4.
Ignoring Colonoscopy Advice; Dry Mouth Acupuncture; Inflamed Tongue, Then Cancer.
5.
Males with early-onset colorectal cancer are at risk, according to a study.
1.
Advances in Cancer Detection: From Genetic Risk to Molecular Biomarkers
2.
Metabolic Reprogramming of the Tumor Microenvironment: Mechanisms, Clinical Relevance, and Emerging Therapeutic Strategies
3.
Multidisciplinary Insights into Diagnosis, Management, and Outcomes in Oncology
4.
Innovative Breakthroughs in Hematology for Modern Medicine
5.
Precision Erythropoietic Modeling for Hematologic Disorders
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Understanding the Role of Screening in Cancer Prevention
2.
Innovations in Hematology
3.
Summary of The Impact of CDK4/6 Inhibition in HR+/HER2- Metastatic Breast Cancer: Insights from PALOMA-2
4.
A Panel Discussion on Clinical Trial End Point for Tumor With PPS > 12 months
5.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VIII
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation